(Q41409532)

30 September 2017

1 reference

title

Enhancing the specificity of prostate-specific antigen (PSA): an overview of PSA density, velocity and age-specific reference ranges (English)

1 reference

30 September 2017

Nixon RG

1

1 reference

PubMed ID

9088275

30 September 2017

Brawer MK

series ordinal

2

1 reference

PubMed ID

9088275

30 September 2017

language of work or name

1 reference

1 March 1997

1 reference

British Journal of Urology

30 September 2017

1 reference

30 September 2017

79 Suppl 1

1 reference

30 September 2017

61-67

1 reference

30 September 2017

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

Making the most out of six systematic sextant biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

The role of increasing detection in the rising incidence of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00803.X

10.1111/J.1464-410X.1997.TB00803.X

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9088275